Mexico Metagenomics Market Size & Outlook, 2023-2030
Mexico metagenomics market, 2018-2030 (US$M)
Related Markets
Mexico metagenomics market highlights
- The Mexico metagenomics market generated a revenue of USD 41.0 million in 2023 and is expected to reach USD 101.5 million by 2030.
- The Mexico market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 41.0 million |
| Market revenue in 2030 | USD 101.5 million |
| Growth rate | 13.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Mexico accounted for 2.0% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 191.5 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.46% in 2023. Horizon Databook has segmented the Mexico metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
High incidence of chronic & infectious diseases and growing medical tourism in the country, due to its cost-effective healthcare services, are significantly boosting the demand for metagenomics tools for clinical applications.
Furthermore, Mexico is the second-largest pharmaceutical market in Latin America after Brazil. It has emerged as one of the potential countries for biopharmaceutical products, owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework.
Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector. In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico metagenomics market size, by product, 2018-2030 (US$M)
Mexico Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
